|
02.07.2014 15:00:19
|
St. Jude Medical Says FDA Warning Letter For Sylmar Facility Resolved
(RTTNews) - Medical device company St. Jude Medical, Inc. (STJ) said it has been notified by the U.S. Food and Drug Administration that issues cited in the Sylmar, California, facility's warning letter have been addressed.
"We take our responsibility as a medical device manufacturer very seriously. We are encouraged by the resolution of the FDA's warning letter and will continue to work to ensure the highest standards are met across our manufacturing facilities," said Dan Starks, Chairman, President and Chief Executive Officer at St. Jude Medical.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu St. Jude Medical Inc.mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu St. Jude Medical Inc.mehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.